过敏性紫癜患儿出院后随访研究进展：更新的认识
Research Progress of the Follow-Up of Henoch-Schtinlein Purpura in Children after Hospital Discharge: Updated Understanding
DOI: 10.12677/ACM.2022.12121585, PDF,    科研立项经费支持
作者: 花媛媛*, 石 艳#：凉山彝族自治州第一人民医院儿科，四川 西昌
关键词: 过敏性紫癜；发病机制；危险因素；随访研究；出院后医疗；Henoch-Schtinlein Purpura； Pathogenesis； Risk Factors； Follow-Up Study； Post-Discharge Medical Care
摘要: 过敏性紫癜(Henoch-Schtinlein purpura, HSP)是儿童期最常见的血管炎。尽管HSP大部分症状均有自愈性，但可合并消化道出血、肠套叠等，其次肾脏损害可影响患儿远期预后结局。尽早干预、改善远期预后、提高生活质量具有重要意义。本文总结国内外过敏性紫癜发病机制、国内外出院后随访研究进展，以期为该类患儿出院后随访管理提供参考。
Abstract: (Henoch-Schtinlein purpura, HSP) is the commonest cause of vasculitis in childhood. Although HSP is a relatively self-limiting disorder in children, gastrointestinal complications may occur, for exam-ple digestive hemorrhage, indigitation. Meanwhile, the renal damages have an effect on the long-term prognosis. Earlier treatment, better outcome and life quality are significant. This article introduces the pathogenesis of HSP, and the research progress for follow-up after discharge at home and abroad, so as to provide the information for management of HSP follow-up.
文章引用：花媛媛, 石艳. 过敏性紫癜患儿出院后随访研究进展：更新的认识[J]. 临床医学进展, 2022, 12(12): 11007-11012. https://doi.org/10.12677/ACM.2022.12121585

参考文献

[1] Jennette, J.C., Falk, R.J. and Bacon, P.A. (2012) Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis & Rheumatology, 65, 1-11.
[2] Kang, Y., Park, J.S., Ha, Y.J., et al. (2014) Differences in Clinical Manifestations and Outcomes between Adult and Child Patients with Henoch-Schönlein Purpura. Journal of Korean Medical Science, 29, 198-203. [Google Scholar] [CrossRef] [PubMed]
[3] Piram, M. and Mahr, A. (2013) Epidemiology of Immunoglobulin A Vasculitis (Henoch-Schönlein): Current State of Knowledge. Current Opinion in Rheumatology, 25, 171-178. [Google Scholar] [CrossRef] 
[4] Gardner-Medwin, J.M., Dolezalova, P., Cummins, C. and Southwood, T.R. (2002) Incidence of Henoch-Schönlein Purpura, Kawasaki Disease, and Rare Vasculitides in Children of Different Ethnic Origins. The Lancet, 360, 1197-1202. [Google Scholar] [CrossRef] 
[5] Yang, Y.H., Hung, C.F., Hsu, C.R., et al. (2005) A Nation-wide Survey on Epidemiological Characteristics of Childhood Henoch-Schönlein Purpura in Taiwan. Rheumatology (Oxford), 44, 618-622. [Google Scholar] [CrossRef] [PubMed]
[6] Dolezalová, P., Telekesová, P., Nemcová, D. and Hoza, J. (2004) Incidence of Vasculitis in Children in the Czech Republic: 2-Year Prospective Epidemiology Survey. The Journal of Rheumatology, 31, 2295-2299.
[7] Shim, J.O., Han, K., Park, S., et al. (2018) Ten-Year Nationwide Population-Based Survey on the Characteristics of Children with Henoch-Schӧnlein Purpura in Korea. Journal of Korean Medical Science, 33, e174. [Google Scholar] [CrossRef] [PubMed]
[8] Leung, A.K.C., Barankin, B. and Leong, K.F. (2020) Henoch-Schönlein Purpura in Children: An Updated Review. Current Pediatric Reviews, 16, 265-276. [Google Scholar] [CrossRef] 
[9] Kim, W.K., Kim, C.J., Yang, E.M., et al. (2021) Risk Fac-tors for Renal Involvement in Henoch-Schönlein Purpura. The Journal of Pediatrics (Rio J), 97, 646-650. [Google Scholar] [CrossRef] [PubMed]
[10] Yang, Y.H., Yu, H.H. and Chiang, B.L. (2014) The Diagnosis and Classification of Henoch-Schönlein Purpura: An Updated Review. Autoimmunity Reviews, 13, 355-358. [Google Scholar] [CrossRef] [PubMed]
[11] 尹薇, 陈晶. 儿童过敏性紫癜免疫机制研究[J]. 中华实用儿科临床杂志, 2017, 32(21): 1604-1607.
[12] López-Mejías, R., Genre, F., Pérez, B.S., et al. (2015) Association of HLA-B*41:02 with Henoch-Schönlein Purpura (IgA Vasculitis) in Spanish Individuals Irrespective of the HLA-DRB1 Status. Arthritis Research & Therapy, 17, Article No. 102. [Google Scholar] [CrossRef] [PubMed]
[13] Jiang, J., Duan, W., Shang, X., et al. (2017) Inducible Nitric Oxide Synthase Gene Polymorphisms Are Associated with a Risk of Nephritis in Henoch-Schönlein Purpura Children. European Journal of Pediatrics, 176, 1035-1045. [Google Scholar] [CrossRef] [PubMed]
[14] Da Dalt, L., Zerbinati, C., Strafella, M.S., et al. (2016) Henoch-Schönlein Purpura and Drug and Vaccine Use in Childhood: A Case-Control Study. Italian Journal of Pediat-rics, 42, Article No. 60. [Google Scholar] [CrossRef] [PubMed]
[15] Piram, M., Gonzalez Chiappe, S., Madhi, F., et al. (2018) Vac-cination and Risk of Childhood IgA Vasculitis. Pediatrics, 142, e20180841. [Google Scholar] [CrossRef] [PubMed]
[16] Jennette, J.C. and Falk, R.J. (1997) Small-Vessel Vasculitis. The New England Journal of Medicine, 337, 1512-1523. [Google Scholar] [CrossRef] 
[17] 张腾飞. 100例小儿紫癜性肾炎临床特点与肾活检病理相关性研究[D]: [硕士学位论文]. 遵义: 遵义医学院, 2018.
[18] Demir, S., Kaplan, O., Celebier, M., et al. (2020) Predictive Biomarkers of IgA Vasculitis with Nephritis by Metabolomic Analysis. Seminars in Arthritis and Rheumatism, 50, 1238-1244. [Google Scholar] [CrossRef] [PubMed]
[19] Rauen, T., Eitner, F., Fitzner, C., et al. (2015) Intensive Sup-portive Care plus Immunosuppression in IgA Nephropathy. The New England Journal of Medicine, 373, 2225-2236. [Google Scholar] [CrossRef] 
[20] Coppo, R., Troyanov, S., Bellur, S., et al. (2014) Validation of the Oxford Classification of IgA Nephropathy in Cohorts with Different Presentations and Treatments. Kidney International, 86, 828-836. [Google Scholar] [CrossRef] [PubMed]
[21] Heineke, M.H., Ballering, A.V., Jamin, A., et al. (2017) New Insights in the Pathogenesis of Immunoglobulin A Vasculitis (Henoch-Schnlein Purpura). Autoimmunity Reviews, 16, 1246-1253. [Google Scholar] [CrossRef] [PubMed]
[22] Koskela, M., Jahnukainen, T., Endén, K., et al. (2019) Methylprednisolone or Cyclosporine a in the Treatment of Henoch-Schönlein Nephritis: A Nationwide Study. Pediatric Nephrology, 34, 1447-1456. [Google Scholar] [CrossRef] [PubMed]
[23] Jauhola, O., Ronkainen, J., Koskimies, O., et al. (2010) Renal Manifestations of Henoch-Schonlein Purpura in a 6-Month Prospective Study of 223 Children. Archives of Disease in Childhood, 95, 877-882. [Google Scholar] [CrossRef] [PubMed]
[24] Ghrahani, R., Ledika, M.A., Sapartini, G. and Setiabudiawan, B. (2014) Age of Onset as a Risk Factor of Renal Involvement in Henoch-Schönlein Purpura. Asia Pacific Allergy, 4, 42-47. [Google Scholar] [CrossRef] [PubMed]
[25] Selewski, D.T., Ambruzs, J.M., Appel, G.B., et al. (2018) Clin-ical Characteristics and Treatment Patterns of Children and Adults with IgA Nephropathy or IgA Vasculitis: Findings from the CureGN Study. Kidney International Reports, 3, 1373-1384. [Google Scholar] [CrossRef] [PubMed]
[26] Chan, H., Tang, Y.L., Lv, X.H., et al. (2016) Risk Factors Associ-ated with Renal Involvement in Childhood Henoch-Schönlein Purpura: A Meta-Analysis. PLOS ONE, 11, e0167346. [Google Scholar] [CrossRef] [PubMed]
[27] Karadağ, Ş.G., Çakmak, F., Çil, B., et al. (2021) The Relevance of Practical Laboratory Markers in Predicting Gastrointestinal and Renal Involvement in Children with Henoch-Schönlein Purpura. Postgraduate Medicine, 133, 272-277. [Google Scholar] [CrossRef] [PubMed]
[28] Yakut, H.I., Kurt, T., Uncu, N., et al. (2020) Predictive Role of Neutrophil to Lymphocyte Ratio and Mean Platelet Volume in Henoch-Schönlein Purpura Related Gastrointestinal and Renal Involvement. Archivos Argentinos de Pediatria, 118, 139-142. [Google Scholar] [CrossRef] [PubMed]
[29] Buscatti, I.M., Casella, B.B., Aikawa, N.E., et al. (2018) Henoch-Schönlein Purpura Nephritis: Initial Risk Factors and Outcomes in a Latin American Tertiary Center. Clinical Rheumatology, 37, 1319-1324. [Google Scholar] [CrossRef] [PubMed]
[30] Saulsbury, F.T. (1999) Henoch-Schönlein Purpura in Children. Report of 100 Patients and Review of the Literature. Medicine (Baltimore), 78, 395-409. [Google Scholar] [CrossRef] [PubMed]
[31] 何松蔚, 王俊宏, 赵骞, 等. 儿童过敏性紫癜复发相关危险因素的meta分析[J]. 中国医药导报, 2021, 18(3): 105-111.
[32] Narchi, H. (2005) Risk of Long Term Renal Impairment and Duration of Follow Up Recommended for Henoch-Schonlein Purpura with Normal or Minimal Urinary Findings: A Systematic Review. Archives of Disease in Childhood, 90, 916-920. [Google Scholar] [CrossRef] [PubMed]
[33] 吴小川. 儿童过敏性紫癜的诊治进展[J]. 中华实用儿科临床杂志, 2013, 28(21): 1605-1608.
[34] Prais, D., Amir, J. and Nussinovitch, M. (2007) Recurrent Henoch-Schönlein Pur-pura in Children. Journal of Clinical Rheumatology, 13, Article No. 25. [Google Scholar] [CrossRef] [PubMed]
[35] Blanco, R., Martínez-Taboada, V.M., Rodríguez-Valverde, V., et al. (1997) Henoch-Schönlein Purpura in Adulthood and Childhood: Two Different Expres-sions of the Same Syndrome. Arthritis & Rheumatology, 40, 859-864. [Google Scholar] [CrossRef] [PubMed]
[36] Lei, W.T., Tsai, P.L., Chu, S.H., et al. (2018) Incidence and Risk Factors for Recurrent Henoch-Schonlein Purpura in Children from a 16-Year Nationalwide Database. Pediatric Rheu-matology, 16, 16-25. [Google Scholar] [CrossRef] [PubMed]
[37] 郑千千, 牛倩, 吴红娟, 等. 医护一体化延伸服务在过敏性紫癜患儿出院后的应用效果观察[J]. 护理研究, 2018, 32(17): 2769-2771.
[38] 李晨悦. 儿童肾脏病慢病管理模式与紫癜性肾炎的示范研究[D]: [硕士学位论文]. 沈阳: 辽宁中医药大学, 2019.

为你推荐